New Advances in Relapsed/Refractory Multiple Myeloma: Frequently Asked Questions on Current and Emerging Treatments

Decera Clinical Education Oncology Podcast · Sep 1, 2020 · 19m

In this episode, Natalie S. Callander, MD, and Shaji Kumar, MD, answer audience questions from a live CCO Webinar on relapsed/refractory myeloma regarding challenges in treating patients in this setting, including optimizing treatment choices and sequencing of treatments, MRD testing in myeloma, promising BCMA-targeted agents, the promise and value of CAR T-cell therapy in myeloma, and more.

Presenters:

Natalie S. Callander, MD

Professor of Medicine

Director, Myeloma Clinical Program

University of Wisconsin Carbone Cancer Center

Madison, Wisconsin

Shaji Kumar, MD

Department of Hematology

Mayo…